CitEc is a RePEc service
providing citation data for Economics since 2001
providing citation data for Economics since 2001
Last updated July, 3 2014 639.049 documents
processed, 16.613.935 references and 6.218.529 citations
[Raw data] [Main indicators] [Most cited papers] [cites used to compute the impact factor] [Recent citations ][documents published in EconPapers] [
Keep updated about new citations] [Missing citations? Add them now] [Incorrect content? Let us know]
Raw data: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| IF: Impact Factor: C2Y / D2Y AIF: Average Impact Factor for series in RePEc in year y DOC: Number of documents published in year y CDO: Cumulative number of documents published until year y CCU: Cumulative number of citations to papers published until year y CIF: Cumulative impact factor CIT: Number of citations to papers published in year y D2Y: Number of articles published in y-1 plus y-2 C2Y: Cites in y to articles published in y-1 plus y-2 %SC: Percentage of selft citations in y to articles published in y-1 plus y-2 CiY: Cites in year y to documents published in year y II: Immediacy Index: CiY / Documents. AII: Average Immediacy Index for series in RePEc in year y |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Most cited documents in this series:
| Year | Title | Cited |
|---|---|---|
| 2004 | A. (2004). Shih, Ya-Chen ; Prasad, Manishi ; Shikiar, Rich ; Wahlqvist, Peter . In: PharmacoEconomics. RePEc:wkh:phecon:v:22:y:2004:i:4:p:225-244. Full description at Econpapers || Download paper | 432 |
| 2006 | Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment: A Review and Consolidation of Quality Assessment. (2006). Claxton, Karl ; Bojke, Laura ; Golder, Su ; Sculpher, Mark ; Philips, Zoe. In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:4:p:355-371. Full description at Econpapers || Download paper | 18 |
| 1998 | The Economics of Parallel Trade. (1998). Danzon, Patricia. In: PharmacoEconomics. RePEc:wkh:phecon:v:13:y:1998:i:3:p:293-304. Full description at Econpapers || Download paper | 16 |
| 2001 | Cost-Effectiveness Analysis and the Consistency of Decision Making: Evidence from Pharmaceutical Reimbursement in Australia (1991 to 1996). (2001). Harris, Anthony ; Mitchell, Andrew ; George, Bethan . In: PharmacoEconomics. RePEc:wkh:phecon:v:19:y:2001:i:11:p:1103-1109. Full description at Econpapers || Download paper | 15 |
| 2012 | Golimumab for the Treatment of Psoriatic Arthritis: A NICE Single Technology Appraisal. (2012). EPSTEIN, DAVID ; Bojke, Laura ; Woolacott, Nerys ; Sculpher, Mark ; Light, Kate ; Bruce, Ian N. ; Yang, Huiqin ; Craig, Dawn . In: PharmacoEconomics. RePEc:wkh:phecon:v:30:y:2012:i:4:p:257-270. Full description at Econpapers || Download paper | 13 |
| 2003 | European Healthcare Policies for Controlling Drug Expenditure. (2003). Szucs, Thomas D. ; Schneeweiss, Sebastian ; Ess, Silvia M.. In: PharmacoEconomics. RePEc:wkh:phecon:v:21:y:2003:i:2:p:89-103. Full description at Econpapers || Download paper | 10 |
| 2000 | Handling Uncertainty in Cost-Effectiveness Models. (2000). Briggs, Andrew H.. In: PharmacoEconomics. RePEc:wkh:phecon:v:17:y:2000:i:5:p:479-500. Full description at Econpapers || Download paper | 9 |
| 2004 | Reconciliation of Economic Concerns and Health Policy: Illustration of an Equity Adjustment Procedure Using Proportional Shortfall. (2004). Brouwer, Werner ; Jan J. V. Busschbach, ; Van Donselaar, Gijs ; Stolk, Elly A. ; Werner B. F. Brouwer, . In: PharmacoEconomics. RePEc:wkh:phecon:v:22:y:2004:i:17:p:1097-1107. Full description at Econpapers || Download paper | 9 |
| 2004 | A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between Countries. (2004). Leidl, Reiner ; Jager, Hans ; Welte, Robert ; Feenstra, Talitha . In: PharmacoEconomics. RePEc:wkh:phecon:v:22:y:2004:i:13:p:857-876. Full description at Econpapers || Download paper | 9 |
| 2008 | An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of Healthcare. (2008). van Exel, Job ; Brouwer, Werner ; van den Berg, Bernard ; Koopmanschap, Marc A. ; Werner B. F. Brouwer, ; N. Job A. van Exel, . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:4:p:269-280. Full description at Econpapers || Download paper | 8 |
| 2000 | Testing the Validity of Cost-Effectiveness Models. (2000). McCabe, Christopher ; Dixon, Simon . In: PharmacoEconomics. RePEc:wkh:phecon:v:17:y:2000:i:5:p:501-513. Full description at Econpapers || Download paper | 7 |
| 2005 | Pharmacoeconomic Analyses Using Discrete Event Simulation. (2005). Caro, Jaime J.. In: PharmacoEconomics. RePEc:wkh:phecon:v:23:y:2005:i:4:p:323-332. Full description at Econpapers || Download paper | 7 |
| 2006 | Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis. (2006). Ades, A. E. ; Lu, Guobing ; Welton, Nicky ; Cooper, Nicola ; Abrams, Keith ; Sutton, Alex ; Sculpher, Mark . In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:1:p:1-19. Full description at Econpapers || Download paper | 7 |
| 2000 | Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio. (2000). O'Hagan, Anthony ; Montmartin, Jacques ; Stevens, John W.. In: PharmacoEconomics. RePEc:wkh:phecon:v:17:y:2000:i:4:p:339-349. Full description at Econpapers || Download paper | 6 |
| 2000 | Assessing Quality in Decision Analytic Cost-Effectiveness Models: A Suggested Framework and Example of Application. (2000). Claxton, Karl ; Fenwick, Elisabeth ; Sculpher, Mark . In: PharmacoEconomics. RePEc:wkh:phecon:v:17:y:2000:i:5:p:461-477. Full description at Econpapers || Download paper | 6 |
| 2002 | Reporting Heterogeneity in the Measurement of Health and Health-Related Quality of Life. (2002). Shmueli, Amir . In: PharmacoEconomics. RePEc:wkh:phecon:v:20:y:2002:i:6:p:405-412. Full description at Econpapers || Download paper | 6 |
| 2011 | Effects of Reference Pricing in Pharmaceutical Markets: A Review. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Matteo Maria. Galizzi, ; Ghislandi, Simone . In: PharmacoEconomics. RePEc:wkh:phecon:v:29:y:2011:i:1:p:17-33. Full description at Econpapers || Download paper | 5 |
| 2002 | Economic Evaluation of Vaccination Programmes: A Consensus Statement Focusing on Viral Hepatitis. (2002). Van Doorslaer, Eddy ; van Hout, Ben A. ; Ginsberg, Gary M. ; Fendrick, Mark A. ; Feilden, Rachel ; Evans, David ; de Wit, Ardine G. ; Antonanzas, Fernando ; Edmunds, John W. ; Pechevis, Marc ; Beutels, Philippe ; Mast, Eric ; Eddy K. A. Van Doorslaer, ; Glick, Henry A.. In: PharmacoEconomics. RePEc:wkh:phecon:v:20:y:2002:i:1:p:1-7. Full description at Econpapers || Download paper | 5 |
| 2002 | Reference-Based Pricing Schemes: Effect on Pharmaceutical Expenditure, Resource Utilisation and Health Outcomes. (2002). Ioannides-Demos, Lisa L. ; McNeil, John J. ; Ibrahim, Joseph E.. In: PharmacoEconomics. RePEc:wkh:phecon:v:20:y:2002:i:9:p:577-591. Full description at Econpapers || Download paper | 5 |
| 2006 | Cost-of-Illness Studies: A Review of Current Methods. (2006). Mullins, Daniel C. ; Blatt, Lisa ; Ju, Jing ; Akobundu, Ebere . In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:9:p:869-890. Full description at Econpapers || Download paper | 5 |
| 2001 | Developing Guidance for Budget Impact Analysis. (2001). Trueman, Paul ; Hutton, John ; Drummond, Michael . In: PharmacoEconomics. RePEc:wkh:phecon:v:19:y:2001:i:6:p:609-621. Full description at Econpapers || Download paper | 5 |
| 2010 | Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Appraisal. (2010). Bagust, Adrian ; Dundar, Yenal ; Dickson, Rumona ; Shaw, Richard ; Fleeman, Nigel ; Greenhalgh, Janette ; McLeod, Claire ; Proudlove, Christine ; Boland, Angela . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:6:p:439-448. Full description at Econpapers || Download paper | 4 |
| 1999 | Determining Clinically Important Differences in Health Status Measures: A General Approach with Illustration to the Health Utilities Index Mark II. (1999). Samsa, Greg ; Lipscomb, Joseph ; Edelman, David ; Matchar, David ; Williams, Rhys G. ; Rothman, Margaret L.. In: PharmacoEconomics. RePEc:wkh:phecon:v:15:y:1999:i:2:p:141-155. Full description at Econpapers || Download paper | 4 |
| 2011 | Health Technology Funding Decision-Making Processes Around the World: The Same, Yet Different. (2011). McCabe, Christopher ; Stafinski, Tania ; Philippon, Donald J. ; Menon, Devidas . In: PharmacoEconomics. RePEc:wkh:phecon:v:29:y:2011:i:6:p:475-495. Full description at Econpapers || Download paper | 4 |
| 2008 | Use of Indirect and Mixed Treatment Comparisons for Technology Assessment. (2008). Sutton, Alex ; Abrams, Keith ; Cooper, Nicola ; Ades, A. E.. In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:9:p:753-767. Full description at Econpapers || Download paper | 4 |
| 2007 | Conjoint Analysis of French and German Parents Willingness to Pay for Meningococcal Vaccine. (2007). Bishai, David ; Saleh, Aneta ; Girod, Isabelle ; Brice, Roger ; Ehreth, Jenifer . In: PharmacoEconomics. RePEc:wkh:phecon:v:25:y:2007:i:2:p:143-154. Full description at Econpapers || Download paper | 4 |
| 2010 | Impact of European Pharmaceutical Price Regulation on Generic Price Competition: A Review. (2010). Puig-Junoy, Jaume . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:8:p:649-663. Full description at Econpapers || Download paper | 4 |
| 2008 | Conducting Discrete Choice Experiments to Inform Healthcare Decision Making: A Users Guide. (2008). Louviere, Jordan ; Lancsar, Emily . In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:8:p:661-677. Full description at Econpapers || Download paper | 4 |
| 2010 | Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?. (2010). Salkeld, Glenn ; Kelly, Patrick J. ; Stockler, Martin R. ; Chim, Lesley . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:6:p:463-475. Full description at Econpapers || Download paper | 4 |
| 2010 | Using Conjoint Analysis and Choice Experiments to Estimate QALY Values: Issues to Consider. (2010). Flynn, Terry N.. In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:9:p:711-722. Full description at Econpapers || Download paper | 3 |
| 2002 | Valuation of Symptomatic Hepatitis A in Adults: Estimates Based on Time Trade-Off and Willingness-To-Pay Measurement. (2002). Jacobs, Jake R ; Meyerhoff, Allen S. ; Moleski, Ronald J.. In: PharmacoEconomics. RePEc:wkh:phecon:v:20:y:2002:i:11:p:739-747. Full description at Econpapers || Download paper | 3 |
| 2012 | Dabigatran Etexilate for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Hip or Knee Surgery: A NICE Single Technology Appraisal. (2012). Carroll, Christopher ; Holmes, Michael ; Papaioannou, Diana . In: PharmacoEconomics. RePEc:wkh:phecon:v:30:y:2012:i:2:p:137-146. Full description at Econpapers || Download paper | 3 |
| 1999 | Pharmacoeconomic Evaluation in the Real World: Effectiveness Versus Efficacy Studies. (1999). Revicki, Dennis A. ; Frank, Lori . In: PharmacoEconomics. RePEc:wkh:phecon:v:15:y:1999:i:5:p:423-434. Full description at Econpapers || Download paper | 3 |
| 2005 | Incorporation of Uncertainty in Health Economic Modelling Studies. (2005). McCabe, Christopher ; Claxton, Karl ; Willan, Andrew ; Sculpher, Mark ; Fryback, Dennis ; Fenwick, Elisabeth ; Briggs, Andrew ; Brennan, Alan ; Akehurst, Ron ; O'Hagan, Anthony ; Spiegelhalter, David . In: PharmacoEconomics. RePEc:wkh:phecon:v:23:y:2005:i:6:p:529-536. Full description at Econpapers || Download paper | 3 |
| 2010 | The Economics of Comparative Effectiveness Studies: Societal and Private Perspectives and their Implications for Prioritizing Public Investments in Comparative Effectiveness Research. (2010). Basu, Anirban ; Conti, Rena ; Meltzer, David . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:10:p:843-853. Full description at Econpapers || Download paper | 3 |
| 2000 | Assessing Health Utilities in Schizophrenia: A Feasibility Study. (2000). Dhawan, Ravinder ; Voruganti, Lakshmi N. ; Zirul, Sandra ; Cortese, Leonardo ; Oyewumi, Kola L. ; Awad, George A.. In: PharmacoEconomics. RePEc:wkh:phecon:v:17:y:2000:i:3:p:273-286. Full description at Econpapers || Download paper | 3 |
| 2009 | Weighting Must Wait: Incorporating Equity Concerns into Cost-Effectiveness Analysis May Take Longer than Expected. (2009). Tsuchiya, Aki ; McCabe, Christopher ; Wailoo, Allan . In: PharmacoEconomics. RePEc:wkh:phecon:v:27:y:2009:i:12:p:983-989. Full description at Econpapers || Download paper | 3 |
| 2011 | Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer: A UK Perspective Considering Duration of Benefit, Long-Term Toxicity and Pattern of Recurrence. (2011). oluboyede, yemi ; McCabe, Christopher ; Hall, Peter S. ; Cameron, David A. ; Round, Jeff ; Hulme, Claire . In: PharmacoEconomics. RePEc:wkh:phecon:v:29:y:2011:i:5:p:415-432. Full description at Econpapers || Download paper | 3 |
| 2004 | Why Did Drug Spending Increase During the 1990s?: A Decomposition Based on Swedish Data. (2004). Gerdtham, Ulf-G ; Ulf- G. Gerdtham, ; Lundin, Douglas ; Ulf-G. Gerdtham, . In: PharmacoEconomics. RePEc:wkh:phecon:v:22:y:2004:i:1:p:29-42. Full description at Econpapers || Download paper | 3 |
| 2012 | Dronedarone for the Treatment of Atrial Fibrillation: A NICE Single Technology Appraisal. (2012). Pepper, Chris ; Palmer, Stephen ; Woolacott, Nerys ; Sarowar, Muhammad ; Stevenson, Matt ; Maund, Emma ; Fox, David ; McKenna, Claire . In: PharmacoEconomics. RePEc:wkh:phecon:v:30:y:2012:i:1:p:35-46. Full description at Econpapers || Download paper | 3 |
| 2005 | Price Differentiation and Transparency in the Global Pharmaceutical Marketplace. (2005). Ridley, David. In: PharmacoEconomics. RePEc:wkh:phecon:v:23:y:2005:i:7:p:651-658. Full description at Econpapers || Download paper | 3 |
| 2008 | The NICE Cost-Effectiveness Threshold: What it is and What that Means. (2008). McCabe, Christopher ; Culyer, Anthony ; Claxton, Karl. In: PharmacoEconomics. RePEc:wkh:phecon:v:26:y:2008:i:9:p:733-744. Full description at Econpapers || Download paper | 3 |
| 2010 | Alitretinoin for Severe Chronic Hand Eczema: A NICE Single Technology Appraisal. (2010). Ingram, John R. ; Griffin, Susan ; Duffy, Steven ; Slack, Russell ; Woolacott, Nerys ; Paulden, Mike ; Sculpher, Mark ; Rodgers, Mark . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:5:p:351-362. Full description at Econpapers || Download paper | 3 |
| 1999 | Willingness to Pay as a Measure of Health Benefits. (1999). Bala, Mohan V. ; Wood, Lisa L. ; Mauskopf, Josephine A.. In: PharmacoEconomics. RePEc:wkh:phecon:v:15:y:1999:i:1:p:9-18. Full description at Econpapers || Download paper | 3 |
| 2010 | Cant Get No Satisfaction? Will Pay for Performance Help?: Toward an Economic Framework for Understanding Performance-Based Risk-Sharing Agreements for Innovative Medical Products. (2010). Towse, Adrian ; Garrison, Louis P.. In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:2:p:93-102. Full description at Econpapers || Download paper | 3 |
| 2005 | Discounting Health Effects in Pharmacoeconomic Evaluations: Current Controversies. (2005). Bos, J. M. ; Annemans, Lieven ; Postma, Maarten J.. In: PharmacoEconomics. RePEc:wkh:phecon:v:23:y:2005:i:7:p:639-649. Full description at Econpapers || Download paper | 3 |
| 2010 | Single Technology Appraisal at the UK National Institute for Health and Clinical Excellence: A Source of Evidence and Analysis for Decision Making Internationally. (2010). Sculpher, Mark . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:5:p:347-349. Full description at Econpapers || Download paper | 3 |
| 2005 | Willingness to Pay for a QALY: Theoretical and Methodological Issues. (2005). Gyrd-Hansen, Dorte . In: PharmacoEconomics. RePEc:wkh:phecon:v:23:y:2005:i:5:p:423-432. Full description at Econpapers || Download paper | 3 |
| 2006 | Recent Developments in Decision-Analytic Modelling for Economic Evaluation. (2006). Weinstein, Milton C.. In: PharmacoEconomics. RePEc:wkh:phecon:v:24:y:2006:i:11:p:1043-1053. Full description at Econpapers || Download paper | 3 |
| 1998 | An Introduction to Markov Modelling for Economic Evaluation. (1998). Briggs, Andrew ; Sculpher, Mark . In: PharmacoEconomics. RePEc:wkh:phecon:v:13:y:1998:i:4:p:397-409. Full description at Econpapers || Download paper | 3 |
Citing documents used to compute impact factor 2:
| Year | Title | See |
|---|---|---|
| 2014 | Access to innovation: Is there a difference in the use of expensive anticancer drugs between French hospitals?. (2014). Chevalier, Julie ; de Pouvourville, Gerard ; Delibes, Michel ; Bonastre, Julia ; Van der Laan, Chantal . In: Health Policy. RePEc:eee:hepoli:v:116:y:2014:i:2:p:162-169. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Regional tenders on biosimilars in Italy: An empirical analysis of awarded prices. (2014). Curto, Sandro ; Garattini, Livio ; Duranti, Silvy ; van de Vooren, Katelijne ; Ghislandi, Simone . In: Health Policy. RePEc:eee:hepoli:v:116:y:2014:i:2:p:182-187. Full description at Econpapers || Download paper | [Citation Analysis] |
Recent citations received in: 2012
| Year | Title | See |
|---|---|---|
| 2012 | Counterfeit or Substandard? Assessing Price and Non-Price Signals of Drug Quality. (2012). Mathur, Aparna ; Bate, Roger ; Jin, Ginger Zhe . In: NBER Working Papers. RePEc:nbr:nberwo:18073. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2012 | Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009. (2012). Lichtenberg, Frank. In: NBER Working Papers. RePEc:nbr:nberwo:18235. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2012 | The Effect of Pharmaceutical Innovation on Longevity: Patient-Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files. (2012). Lichtenberg, Frank. In: NBER Working Papers. RePEc:nbr:nberwo:18552. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2012 | The Authorsâ Reply. (2012). Delwel, Gepke ; Hoomans, Ties ; Roer, Nicole ; Severens, Johan . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:10:p:980-980. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2012 | Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6â11 Years. (2012). McKenna, Claire ; Griffin, Susan ; Walker, Simon ; Woolacott, Nerys ; Wright, Kath ; Burch, Jane ; Paton, James . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:11:p:991-1004. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2012 | Bevacizumab for Metastatic Colorectal Cancer. (2012). Pandor, Abdullah ; Whyte, Sophie ; Stevenson, Matt . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:12:p:1119-1132. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2012 | Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura. (2012). Jenkinson, David ; Jia, Xueli ; Mowatt, Graham ; Boyers, Dwayne . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:6:p:483-495. Full description at Econpapers || Download paper | [Citation Analysis] |
Recent citations received in: 2011
| Year | Title | See |
|---|---|---|
| 2011 | Competition and the Reference Pricing Scheme for pharmaceuticals. (2011). Ghislandi, Simone . In: Journal of Health Economics. RePEc:eee:jhecon:v:30:y:2011:i:6:p:1137-1149. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2011 | Valuing qalys at the end of life. (2011). Sanchez Martinez, Fernando Ignacio ; pinto-prades, jose-luis ; Corbacho, Belen ; Jose Luis Pinto Prades, ; PintoPrades, Jose Luis. In: Working Papers. RePEc:pab:wpaper:11.15. Full description at Econpapers || Download paper | [Citation Analysis] |
Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.
Source data used to compute the impact factor of RePEc series.